<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04156412</url>
  </required_header>
  <id_info>
    <org_study_id>2019/127/HP</org_study_id>
    <nct_id>NCT04156412</nct_id>
  </id_info>
  <brief_title>AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy</brief_title>
  <acronym>AXONE-Acute-2</acronym>
  <official_title>AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MicroPort CRM</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot study to evaluate the performance of a lead below 2 French with specific distal shape
      to deliver efficient LV pacing
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LV Bi-zone pacing success rate</measure>
    <time_frame>30 min</time_frame>
    <description>Percent of patients where the placement of the AXONE lead provides two distant LV pacing vectors matching: Pacing Threshold ≤ 3.5V/0.5ms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LV pacing success rate</measure>
    <time_frame>30 min</time_frame>
    <description>Percent of patients where the placement of the AXONE lead allows at least one LV pacing vectors matching: Pacing Threshold ≤ 3.5V/0.5ms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device or Implant testing procedure-related Adverse Events</measure>
    <time_frame>1 month post intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical performance (1)</measure>
    <time_frame>30 min</time_frame>
    <description>LV pacing threshold (Volt)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrical performance (2)</measure>
    <time_frame>30 min</time_frame>
    <description>LV pacing impedance (Ohm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AXONE Implant Efficiency (1)</measure>
    <time_frame>30 min</time_frame>
    <description>procedure time for successful placement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AXONE Implant Efficiency (2)</measure>
    <time_frame>30 min</time_frame>
    <description>fluoroscopic time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AXONE Implant Efficiency (3)</measure>
    <time_frame>30 min</time_frame>
    <description>radiation dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AXONE Implant Efficiency (4)</measure>
    <time_frame>30 min</time_frame>
    <description>handling assessment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV multipoint pacing success</measure>
    <time_frame>30 min</time_frame>
    <description>the placement of the AXONE provides two pacing vectors matching</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Cardiac Resynchronisation Therapy</condition>
  <arm_group>
    <arm_group_label>Implant test procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implant test procedure</intervention_name>
    <description>Implant test procedure with new LV quadripolar lead before a standard implantation for Cardiac resynchronisation therapy</description>
    <arm_group_label>Implant test procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient aged ≥18 years old.

          -  Patient presenting a CRT-P or CRT-D indication according to the latest ESC
             guidelines1.

          -  Primary implant of a CRT device (including upgrade from a single or dual-chamber
             pacemaker or ICD).

          -  Signed and dated informed consent.

        Exclusion Criteria:

          -  Class IV of NYHA (ambulatory or not).

          -  Allergy to contrast media used for imaging during cardiac catheterization.

          -  Severe Renal Failure (clearance of creatinine according to Modification of diet in
             renal disease formula (MDRD) &lt; 30ml/mn/m²).

          -  Previous failure of catheterization of the coronary sinus, or previous failure of left
             ventricular lead implantation.

          -  Already included in another clinical study involving intra-cardiac active implantable
             device, or participation to any other clinical trial in the last 2 weeks.

          -  Vulnerable patient such as person deprived of liberty by administrative or judicial
             decision or placed under judicial protection (guardianship or supervision).

          -  Known pregnancy, breastfeeding or women in childbearing age without an adequate
             contraceptive method with a known failure rate &lt; 1%.-
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric ANSELME, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frédéric ANSELME, Pr</last_name>
    <phone>+3323288</phone>
    <phone_ext>8990</phone_ext>
    <email>frederic.anselme@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe RITTER, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clermont-Ferrand University Hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Jean, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier KLUG, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe LECLERCQ, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric ANSELME, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roger VILLUENDAS, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquín OSCA, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 5, 2019</study_first_submitted>
  <study_first_submitted_qc>November 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2019</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>quadripolar LV leads</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

